NIH Scientists Meet in Secret, Won't Say Why
Published Date: 12/15/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in January 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund exciting research in behavioral science, public health, and cancer. If you’re involved in these fields, keep an eye on these dates—they’re key to getting research support rolling!
Analyzed Economic Effects
8 provisions identified: 8 benefits, 0 costs, 0 mixed.
Career Development (K) Awards Reviewed Jan 13
On January 13, 2026, a closed virtual panel will review Career Development (K) grant applications in behavioral science. The meetings are closed to protect confidential trade secrets and personal information while deciding which applications move forward for funding.
Public Health Applications Reviewed Jan 14
On January 14, 2026, a closed virtual Special Emphasis Panel will review grant applications on social and community influences and public health approaches. The panel will evaluate and decide on funding while protecting confidential and personal information.
Oncology Fellowships Reviewed Jan 15
On January 15, 2026, a closed virtual panel will review fellowship (oncology) grant applications to evaluate and rank candidates for funding. The meetings are closed to protect applicants' confidential and proprietary information.
Nutrition, Obesity, Diabetes Research Reviewed Jan 16
On January 16, 2026, a closed virtual PAR panel will review grant applications for behavioral interventions related to nutrition, diet, obesity, and diabetes. Panels will review and evaluate applications while keeping personal and proprietary information confidential.
Small Business Grant Panel Meets Jan 22
On January 22, 2026, a closed virtual panel titled 'Small Business: Cell, Molecular Biology, Instrumentation, and Assay Development' will review and evaluate small-business grant applications. The meetings are closed to protect confidential trade secrets and personal information of applicants.
Environmental Health Disparities Centers Reviewed Jan 27-28
On January 27–28, 2026, a closed virtual panel will review applications for RFA‑MD‑24‑010: Environmental Health Disparities Centers (P50). The panel will evaluate grant applications and protect confidential and proprietary applicant information.
Institutional Training Panel Meets Jan 28-29
On January 28–29, 2026, a closed virtual Institutional Training and Education Review Panel will review and evaluate grant applications for institutional training programs. Meetings are closed to protect confidential information about applicants and institutions.
Cancer Center Support Grants Reviewed Jan 28-29
On January 28–29, 2026, a closed virtual PAR‑21‑321 panel will review Cancer Center Support Grant applications to evaluate and rank candidates for funding. The meetings will protect applicants' confidential and proprietary information.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-22791, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 9, 2026, to review grant applications about infectious disease and immunology. These meetings are private to protect secret research ideas and personal info. Scientists applying for grants and NIH staff are the main players, with no new costs or deadlines announced.
Next: 2025-22793, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 13, 2026, to review grant applications about celiac disease research. These meetings are private to protect secret ideas and personal info. Scientists applying for grants and the public should note this important step in funding decisions, but no new costs or deadlines are announced.